Prominex Receives NIH RADx® Tech Funding to Advance the 5-minute Sample-to-Answer Molecular Assay System for Infectious Disease Testing
“We are proud to have been selected to participate in both their high-performance and accessible tests programs. We are pleased to report that we recently completed the third of four milestones in phase I of the high-performance program. Prominex was founded on the principles of democratizing diagnostics with affordable and rapid tests and our solution holds significant promise to enable individuals with and without accessible needs to test for respiratory infections easily and accurately from the comfort of their own homes.”
-Paul Thomas, CEO